生长分化因子-15作为急性呼吸衰竭幸存者肌力与恢复的生物标志物
在142例年龄≥65岁的急性呼吸衰竭幸存者中,出院前一周测得的血清GDF-15较高与膈肌、肢体和握力较弱横断面相关,并与6个月内功能恢复率较低纵向相关,且独立于年龄、性别、既往残疾、合并症、衰弱、APACHE II评分和同期白细胞介素-6水平。
要点
- 出院前血清GDF-15较高与急性呼吸衰竭幸存者肌力较弱相关。
- GDF-15较高与6个月内功能恢复率较低独立相关。
- GDF-15或可辅助识别肌力恢复不良的老年幸存者。
核心结论
- 出院前血清GDF-15较高与老年急性呼吸衰竭幸存者肌力较弱及6个月内功能恢复率较低独立相关。
研究设计与样本
- 研究纳入142例年龄≥65岁的急性呼吸衰竭幸存者,于出院前一周测量血清GDF-15,并进行横断面和纵向分析。
主要发现
- 出院前一周血清GDF-15较高与膈肌、肢体和握力较弱横断面相关。
- 血清GDF-15较高与6个月内功能恢复率较低纵向相关。
- 上述关联独立于年龄、性别、既往残疾、合并症、衰弱、APACHE II评分和同期白细胞介素-6水平。
临床怎么用
- 对老年急性呼吸衰竭幸存者,出院前可考虑检测血清GDF-15以辅助评估肌力和功能恢复风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Muscle mitochondrial dysfunction is implicated in intensive care unit-acquired weakness, but there is no serum biomarker of muscle mitochondrial function for critical illness survivors. Higher serum growth differentiation factor-15 (GDF-15) is a biomarker of inherited mitochondrial myopathy disease and is associated with mortality in several age-related diseases. Among 142 older (age ≥ 65 years) survivors of acute respiratory failure, we found that higher serum GDF-15 measured during the week prior to hospital discharge was cross-sectionally associated with weaker diaphragm, limb and hand-grip strength, and longitudinally associated with lower rates of functional recovery over 6 months, independent of age, sex, pre-existing disability, comorbidity, frailty, Acute Physiology and Chronic Health Evaluation II scores and concurrent interleukin-6 levels.
引用
- Rosenberg BJ, Hirano M, Quinzii CM, et al. Growth differentiation factor-15 as a biomarker of strength and recovery in survivors of acute respiratory failure. Thorax. 2019. PMID: 31534031. doi:10.1136/thoraxjnl-2019-213621
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。